San Francisco-based Mendra, a biopharma aiming to advance promising therapies for rare disease medicines, has announced its ...
US pharma major Gilead Sciences (Nasdaq: GILD) says The New England Journal of Medicine has published full Phase III data for ...
UK pharma major GSK’s Nucala (mepolizumab) has recently received approval in China as add-on maintenance treatment for adults ...
The Gates Foundation, Novo Nordisk Foundation, and Wellcome have said they will award $60 million in new grant funding over ...
DelveInsight says the cystinosis treatment market across the USA, EU4, UK and Japan totaled about $250 million in 2024, with ...
US clinical-stage biotech Corxel Pharmaceuticals, dedicated to developing innovative therapies for patients with ...
US healthcare company Sagebrush Health Services, a non-profit organization serving more than 10,000 Nevada patients, has ...
Texas, USA-based IntraBio revealed that the European Commission granted marketing authorization to Aqneursa (levacetylleucine ...
A U.S.-based clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company conducts ...
India’s Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has launched the world’s first biosimilar of nivolumab in India under the brand name Tishtha, ...
The 44th Annual JP Morgan Healthcare Conference saw a focus on internal pipeline prioritization and bolt-on licensing ...
US ophthalmology specialist Ocular Therapeutix announced that David Robinson has agreed to join the company as global chief commercial officer (CCO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback